Eli Lilly and Company

105B Days Grade A/B Aseptic Operator

Indianapolis, Indiana, United States

Not SpecifiedCompensation
Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical Manufacturing, BiotechnologyIndustries

Requirements

Candidates must have direct manufacturing experience operating automatic, manual, or semi-automated equipment in production processes in accordance with operating procedures. The role requires adherence to site safety policies and procedures, maintaining a safe work environment, and complying with quality, safety, and environmental guidelines.

Responsibilities

The 105B Aseptic Operator is responsible for running a partially automated process to fill material within the Grade B/A space, including preparing filling equipment, assembling and autoclaving it. They will collect and use data from computer systems for analysis and documentation, support qualification and validation activities, execute ticket and procedure instructions, identify abnormal processing conditions and escalate appropriately, provide information to technical services, and maintain process/work areas in a clean and organized state while promoting Quality, learning, understanding, and strict adherence to Good Manufacturing Practices (GMP), cGMP guidelines, and good documentation practices.”} 2024-02-29T13:30:00Z

Skills

GMP
cGMP
Data Analysis
Operating Equipment
Documentation
Quality Control
Process Monitoring
Autoclaving
Automation

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI